Image 10
Image 10
Image
Image
Image 3
Image 3
Image 11
Image 11
Facial nerve schwannomas preferentially involve the geniculate ganglion as the second most common tumor of that location after hemangiomas, making careful imaging characterization essential to avoid misdiagnosis
The classic imaging combination of a discrete enhancing mass on MRI with smooth bone remodeling on CT is highly specific for geniculate ganglion schwannoma and guides treatment planning
Loss of lacrimation occurs when the tumor extends into the greater superficial petrosal nerve, whereas conductive hearing loss results from tympanic segment involvement, allowing clinicopathologic correlation
Cystic degeneration and hemorrhagic changes are seen in larger schwannomas and may alter their signal characteristics on MRI but do not change the benign diagnostic impression
A wait-and-scan strategy is appropriate for nongrowing asymptomatic or minimally symptomatic lesions, whereas symptomatic or enlarging tumors warrant consideration of microsurgical excision with facial nerve repair or stereotactic radiosurgery
Describe a geniculate ganglion schwannoma as an avidly enhancing mass at the geniculate fossa with smooth benign remodeling of the bony ganglion fossa, noting any extension into adjacent segments (GSPN, tympanic, labyrinthine, or middle cranial fossa) and the presence of cystic or hemorrhagic components, which collectively confirm the benign nature while quantifying surgical implications.